(Q45887791)

17 December 2017

title

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo (English)

1 reference

17 December 2017

1 reference

Fueyo J

1

1 reference

17 December 2017

Gomez-Manzano C

2

1 reference

17 December 2017

Yung WK

3

1 reference

17 December 2017

Liu TJ

4

1 reference

17 December 2017

Alemany R

5

1 reference

17 December 2017

McDonnell TJ

6

1 reference

17 December 2017

Shi X

7

1 reference

17 December 2017

Rao JS

8

1 reference

17 December 2017

Levin VA

9

1 reference

17 December 2017

Kyritsis AP

10

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

17 December 2017

published in

Nature Medicine

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

page(s)

685-690

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/nm0698-685

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

The transcription factor E2F-1 is a downstream target of RB action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Identification of a cellular transcription factor involved in E1A trans-activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Expression of transcription factor E2F1 induces quiescent cells to enter S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Correlation of p53 immunoreactivity and sequencing in patients with glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

p53 and E2F-1 cooperate to mediate apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

E2F-1 functions in mice to promote apoptosis and suppress proliferation

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Tumor induction and tissue atrophy in mice lacking E2F-1

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Rearrangement of the p53 gene in human osteogenic sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Suppression of human glioma growth by adenovirus-mediated Rb gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Genetic determinants of p53-induced apoptosis and growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Application of an immunoperoxidase monolayer assay for the detection of arboviral antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0698-685

7 January 2021

Identifiers

DOI

10.1038/NM0698-685

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017